Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery

Division of Cardiothoracic Surgery, Columbia University College of Physicians and Surgeons, New York, New York 10032, USA. JJD11@columbia.edu

OBJECTIVES: Our recent experience with outpatient left ventricular assist device (LVAD) support is presented to demonstrate the possibilities and limitations of long-term outpatient mechanical circulatory assistance. BACKGROUND: The experience with inpatient LVAD support as a bridge to transplantation has proved the efficacy of such therapy in improving circulatory hemodynamic status, restoring normal end-organ function and facilitating patient rehabilitation. With miniaturization of the power supplies and controllers, such mechanical circulatory support can now be accomplished in an outpatient setting. METHODS: Between March 1993 and February 1997, 32 patients (26 male, 6 female, mean [+/-SEM] age 49 +/- 15 years) underwent implantation of the ThermoCardiosystems (TCI) Heartmate vented electric (VE) LVAD. The VE LVAD is powered by batteries worn on shoulder holsters and is operated by a belt-mounted system controller, allowing unrestricted patient ambulation and hospital discharge. RESULTS: Mean duration of support was 122 +/- 26 days (range 3 to 605), with a survival rate to transplantation or explantation of 78%. Nineteen patients were discharged from the hospital on mean postoperative day 41 +/- 4 (range 17 to 68), for an outpatient support time of 108 +/- 30 days (range 2 to 466). Four patients underwent early transplantation and could not participate in the discharge program, and three patients currently await discharge. The complication rate was not statistically different from that encountered in our previous 52 patients with a pneumatic LVAD. CONCLUSIONS: Outpatient LVAD support is safe and provides improved quality of life for patients awaiting transplantation. Wearable and totally implantable LVADs should be studied as permanent treatment options for patients who are not candidates for heart transplantation.

This article has been cited by other articles:

				T. Mizuno Feasibility of cell transplantation with a left ventricular assist device to improve the success rate of left ventricular assist device removal: the first experiment Interact CardioVasc Thorac Surg, January 1, 2011; 12(1): 10 - 14. [Abstract] [Full Text] [PDF]

				S. Aslam, M. Hernandez, J. Thornby, B. Zeluff, and R. O. Darouiche Risk Factors and Outcomes of Fungal Ventricular-Assist Device Infections Clinical Infectious Diseases, March 1, 2010; 50(5): 664 - 671. [Abstract] [Full Text] [PDF]

				E. A. Genovese, M. A. Dew, J. J. Teuteberg, M. A. Simon, J. Kay, M. P. Siegenthaler, J. K. Bhama, C. A. Bermudez, K. L. Lockard, S. Winowich, et al. Incidence and Patterns of Adverse Event Onset During the First 60 Days After Ventricular Assist Device Implantation Ann. Thorac. Surg., October 1, 2009; 88(4): 1162 - 1170. [Abstract] [Full Text] [PDF]

				S. V. Raman, T. Tran, O. P. Simonetti, and B. Sun Dynamic computed tomography to determine cardiac output in patients with left ventricular assist devices. J. Thorac. Cardiovasc. Surg., May 1, 2009; 137(5): 1213 - 1217. [Abstract] [Full Text] [PDF]

				J. Haft, W. Armstrong, D. B. Dyke, K. D. Aaronson, T. M. Koelling, D. J. Farrar, and F. D. Pagani Hemodynamic and Exercise Performance With Pulsatile and Continuous-Flow Left Ventricular Assist Devices Circulation, September 11, 2007; 116(11_suppl): I-8 - I-15. [Abstract] [Full Text] [PDF]

				A. Zierer, S. J. Melby, R. K. Voeller, T. J. Guthrie, G. A. Ewald, K. Shelton, M. K. Pasque, M. R. Moon, R. J. Damiano Jr, and N. Moazami Late-Onset Driveline Infections: The Achilles' Heel of Prolonged Left Ventricular Assist Device Support Ann. Thorac. Surg., August 1, 2007; 84(2): 515 - 520. [Abstract] [Full Text] [PDF]

				S. G. Drakos, A. G. Kfoury, J. W. Long, J. C. Stringham, E. M. Gilbert, B. D. Horne, M.-B. E. Hagan, K. Nelson, and D. G. Renlund Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure Eur J Heart Fail, August 1, 2007; 9(8): 845 - 849. [Abstract] [Full Text] [PDF]

				N. H. Thoennissen, M. Schneider, A. Allroggen, M. Ritter, R. Dittrich, C. Schmid, H. H. Scheld, E. B. Ringelstein, and D. G. Nabavi High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1159 - 1166. [Abstract] [Full Text] [PDF]

				H. Tsukui, J. J. Teuteberg, S. Murali, D. M. McNamara, J. R. Buchanan, S. Winowich, E. Stanford, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Biventricular Assist Device Utilization for Patients with Morbid Congestive Heart Failure: A Justifiable Strategy Circulation, August 30, 2005; 112(9_suppl): I-65 - I-72. [Abstract] [Full Text] [PDF]

				T. Mizuno, R. D. Weisel, and R.-K. Li Reloading the heart: A new animal model of left ventricular assist device removal J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 99 - 106. [Abstract] [Full Text] [PDF]

				R. D. Patten, D. DeNofrio, M. El-Zaru, R. Kakkar, J. Saunders, F. Celestin, K. Warner, H. Rastegar, K. R. Khabbaz, J. E. Udelson, et al. Ventricular Assist Device Therapy Normalizes Inducible Nitric Oxide Synthase Expression and Reduces Cardiomyocyte Apoptosis in the Failing Human Heart J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1419 - 1424. [Abstract] [Full Text] [PDF]

				J. A. Morgan, R. John, V. Rao, A. D. Weinberg, B. J. Lee, P. A. Mazzeo, M. R. Flannery, J. M. Chen, M. C. Oz, and Y. Naka Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1309 - 1316. [Abstract] [Full Text] [PDF]

				D. G. Nabavi, J. Stockmann, C. Schmid, M. Schneider, D. Hammel, H. H. Scheld, and E. B. Ringelstein Doppler microembolic load predicts risk of thromboembolic complications in Novacor patients J. Thorac. Cardiovasc. Surg., July 1, 2003; 126(1): 160 - 167. [Abstract] [Full Text] [PDF]

				C. M. N. O'Malley, R. J. Frumento, B. Mets, Y. Naka, and E. Bennett-Guerrero Abnormal gastric tonometric variables and vasoconstrictor use after left ventricular assist device insertion Ann. Thorac. Surg., June 1, 2003; 75(6): 1886 - 1891. [Abstract] [Full Text] [PDF]

				E. L. Kukuy, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support Card. Surg. Adult, January 1, 2003; 2(2003): 1491 - 1506. [Full Text]

				R. John, H. A. Rajasinghe, J. M. Chen, A. D. Weinberg, P. Sinha, D. M. Mancini, Y. Naka, M. C. Oz, C. R. Smith, E. A. Rose, et al. Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy Ann. Thorac. Surg., August 1, 2001; 72(2): 440 - 449. [Abstract] [Full Text] [PDF]

				N. de Jonge, H. Kirkels, J. R. Lahpor, C. Klopping, E. J. Hulzebos, A. Brutel de la Riviere, and E. O. Robles de Medina Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: An outlook for permanent assisting? J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1794 - 1799. [Abstract] [Full Text] [PDF]

				D. Marelli, H. Laks, D. Fazio, M. A. Hamilton, G. C. Fonarow, D. A. Meehan, and J. D. Moriguchi Mechanical assist strategy using the BVS 5000i for patients with heart failure Ann. Thorac. Surg., July 1, 2000; 70(1): 59 - 66. [Abstract] [Full Text] [PDF]

				J. R Pepper Surgery for heart failure: options and outcomes Perfusion, July 1, 2000; 15(4): 287 - 293. [PDF]

				A. El-Banayosy, L. Arusoglu, L. Kizner, G. Tenderich, K. Minami, K. Inoue, and R. Korfer NOVACOR LEFT VENTRICULAR ASSIST SYSTEM VERSUS HEARTMATE VENTED ELECTRIC LEFT VENTRICULAR ASSIST SYSTEM AS A LONG-TERM MECHANICAL CIRCULATORY SUPPORT DEVICE IN BRIDGING PATIENTS: A PROSPECTIVE STUDY J. Thorac. Cardiovasc. Surg., March 1, 2000; 119(3): 581 - 587. [Abstract] [Full Text] [PDF]

				D. L.S. Morales, K. A. Catanese, D. N. Helman, M. R. Williams, A. Weinberg, D. J. Goldstein, E. A. Rose, and M. C. Oz SIX-YEAR EXPERIENCE OF CARING FOR FORTY-FOUR PATIENTS WITH A LEFT VENTRICULAR ASSIST DEVICE AT HOME: SAFE, ECONOMICAL, NECESSARY J. Thorac. Cardiovasc. Surg., February 1, 2000; 119(2): 251 - 259. [Abstract] [Full Text] [PDF]

				C. Schmid, D. Hammel, M. C. Deng, M. Weyand, H. Baba, T. D. T. Tjan, G. Drees, N. Roeder, C. Schmidt, and H. H. Scheld Ambulatory Care of Patients With Left Ventricular Assist Devices Circulation, November 9, 1999; 100(90002): II-224 - II-228. [Abstract] [Full Text] [PDF]

				L. Arusoglu, R. Koerfer, G. Tenderich, W. A. Alexander, and A. El-Banayosy A novel method to reduce device-related infections in patients supported with the HeartMate device Ann. Thorac. Surg., November 1, 1999; 68(5): 1875 - 1877. [Abstract] [Full Text] [PDF]